Shing‐Jong Lin
Impact in
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
-
- Heart Failure Treatment and Management
- Acute Myocardial Infarction Research
- Blood Pressure and Hypertension Studies
Papers in
-
- Blood Pressure and Hypertension Studies 6
-
- Acute Kidney Injury Research 3
- Co-authors
- Jaw‐Wen Chen (21 shared papers)Tse‐Min Lu (11 shared papers)Hsin‐Bang Leu (16 shared papers)Shao‐Sung Huang (8 shared papers)Min‐Ji Charng (4 shared papers)Ying‐Hwa Chen (5 shared papers)Po‐Hsun Huang (13 shared papers)Chin‐Chou Huang (12 shared papers)
- Journals
- Clinical Cardiology (4 papers)PLoS ONE (3 papers)Journal of Clinical Hypertension (3 papers)Journal of Cellular and Molecular Medicine (2 papers)Journal of Cellular Biochemistry (2 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Shing‐Jong Lin
65 papers receiving 1.7k citations
Shing‐Jong Lin's Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 381
- Cardiology and Cardiovascular Medicine 338
- Nephrology 127
- Biological Psychiatry 11
- Neurology 112
Countries citing papers authored by Shing‐Jong Lin
This map shows the geographic impact of Shing‐Jong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shing‐Jong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shing‐Jong Lin more than expected).
Fields of papers citing papers by Shing‐Jong Lin
This network shows the impact of papers produced by Shing‐Jong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shing‐Jong Lin. The network helps show where Shing‐Jong Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Shing‐Jong Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Systemic immune‐inflammation index (SII) predicted clinical outcome in patients with coronary artery disease Hit paper breakdown → | 2020 | 519 |
| 2 | 2021 | 91 | |
| 3 | 2003 | 66 | |
| 4 | 2008 | 63 | |
| 5 | 2010 | 63 | |
| 6 | 2010 | 53 | |
| 7 | 2007 | 41 | |
| 8 | 2018 | 40 | |
| 9 | 2018 | 38 | |
| 10 | 2013 | 35 | |
| 11 | 2011 | 32 | |
| 12 | 2005 | 31 | |
| 13 | 2009 | 30 | |
| 14 | 2009 | 29 | |
| 15 | 2020 | 28 | |
| 16 | 1999 | 27 | |
| 17 | 2013 | 27 | |
| 18 | 2021 | 27 | |
| 19 | 2007 | 26 | |
| 20 | 2007 | 25 |
About Shing‐Jong Lin
Shing‐Jong Lin is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology, Surgery, Immunology and Physiology, having authored 66 papers that have together received 1.7k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (6 papers), Atherosclerosis and Cardiovascular Diseases (6 papers), Nitric Oxide and Endothelin Effects (5 papers), Cerebral Venous Sinus Thrombosis (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Acute Kidney Injury Research (3 papers), Coronary Interventions and Diagnostics (3 papers) and Congenital Heart Disease Studies (3 papers). The work is most often cited by research in Oncology (381 citations), Cardiology and Cardiovascular Medicine (338 citations), Nephrology (127 citations), Biological Psychiatry (11 citations) and Neurology (112 citations). Shing‐Jong Lin has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Jaw‐Wen Chen, Tse‐Min Lu, Hsin‐Bang Leu, Shao‐Sung Huang, Min‐Ji Charng, Ying‐Hwa Chen, Po‐Hsun Huang, Chin‐Chou Huang, Tao-Cheng Wu and Wan‐Leong Chan. Their work appears in journals such as Clinical Cardiology, PLoS ONE, Journal of Clinical Hypertension, Journal of Cellular and Molecular Medicine and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.